img

Global Tuberculosis Vaccination Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tuberculosis Vaccination Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme
Tuberculosis Vaccination report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tuberculosis Vaccination market is projected to reach US$ 93 million in 2029, increasing from US$ 76 million in 2022, with the CAGR of 3.0% during the period of 2024 to 2029. Demand from Self-Procurement and UNICEF are the major drivers for the industry.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guérin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tuberculosis Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine

Segment by Application


Self-Procurement
UNICEF
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tuberculosis Vaccination market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tuberculosis Vaccination, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tuberculosis Vaccination industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tuberculosis Vaccination in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tuberculosis Vaccination introduction, etc. Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Tuberculosis Vaccination market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Tuberculosis Vaccination Market Overview
1.1 Tuberculosis Vaccination Product Overview
1.2 Tuberculosis Vaccination Market Segment by Type
1.2.1 Immune Vaccine
1.2.2 Therapy Vaccine
1.3 Global Tuberculosis Vaccination Market Size by Type
1.3.1 Global Tuberculosis Vaccination Market Size Overview by Type (2018-2029)
1.3.2 Global Tuberculosis Vaccination Historic Market Size Review by Type (2018-2024)
1.3.3 Global Tuberculosis Vaccination Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tuberculosis Vaccination Sales Breakdown by Type (2018-2024)
1.4.2 Europe Tuberculosis Vaccination Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Tuberculosis Vaccination Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Tuberculosis Vaccination Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Tuberculosis Vaccination Sales Breakdown by Type (2018-2024)
2 Global Tuberculosis Vaccination Market Competition by Company
2.1 Global Top Players by Tuberculosis Vaccination Sales (2018-2024)
2.2 Global Top Players by Tuberculosis Vaccination Revenue (2018-2024)
2.3 Global Top Players by Tuberculosis Vaccination Price (2018-2024)
2.4 Global Top Manufacturers Tuberculosis Vaccination Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tuberculosis Vaccination Market Competitive Situation and Trends
2.5.1 Tuberculosis Vaccination Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Tuberculosis Vaccination Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccination as of 2022)
2.7 Date of Key Manufacturers Enter into Tuberculosis Vaccination Market
2.8 Key Manufacturers Tuberculosis Vaccination Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tuberculosis Vaccination Status and Outlook by Region
3.1 Global Tuberculosis Vaccination Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tuberculosis Vaccination Historic Market Size by Region
3.2.1 Global Tuberculosis Vaccination Sales in Volume by Region (2018-2024)
3.2.2 Global Tuberculosis Vaccination Sales in Value by Region (2018-2024)
3.2.3 Global Tuberculosis Vaccination Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Tuberculosis Vaccination Forecasted Market Size by Region
3.3.1 Global Tuberculosis Vaccination Sales in Volume by Region (2024-2029)
3.3.2 Global Tuberculosis Vaccination Sales in Value by Region (2024-2029)
3.3.3 Global Tuberculosis Vaccination Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tuberculosis Vaccination by Application
4.1 Tuberculosis Vaccination Market Segment by Application
4.1.1 Self-Procurement
4.1.2 UNICEF
4.1.3 Other
4.2 Global Tuberculosis Vaccination Market Size by Application
4.2.1 Global Tuberculosis Vaccination Market Size Overview by Application (2018-2029)
4.2.2 Global Tuberculosis Vaccination Historic Market Size Review by Application (2018-2024)
4.2.3 Global Tuberculosis Vaccination Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tuberculosis Vaccination Sales Breakdown by Application (2018-2024)
4.3.2 Europe Tuberculosis Vaccination Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Tuberculosis Vaccination Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Tuberculosis Vaccination Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Tuberculosis Vaccination Sales Breakdown by Application (2018-2024)
5 North America Tuberculosis Vaccination by Country
5.1 North America Tuberculosis Vaccination Historic Market Size by Country
5.1.1 North America Tuberculosis Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tuberculosis Vaccination Sales in Volume by Country (2018-2024)
5.1.3 North America Tuberculosis Vaccination Sales in Value by Country (2018-2024)
5.2 North America Tuberculosis Vaccination Forecasted Market Size by Country
5.2.1 North America Tuberculosis Vaccination Sales in Volume by Country (2024-2029)
5.2.2 North America Tuberculosis Vaccination Sales in Value by Country (2024-2029)
6 Europe Tuberculosis Vaccination by Country
6.1 Europe Tuberculosis Vaccination Historic Market Size by Country
6.1.1 Europe Tuberculosis Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tuberculosis Vaccination Sales in Volume by Country (2018-2024)
6.1.3 Europe Tuberculosis Vaccination Sales in Value by Country (2018-2024)
6.2 Europe Tuberculosis Vaccination Forecasted Market Size by Country
6.2.1 Europe Tuberculosis Vaccination Sales in Volume by Country (2024-2029)
6.2.2 Europe Tuberculosis Vaccination Sales in Value by Country (2024-2029)
7 Asia-Pacific Tuberculosis Vaccination by Region
7.1 Asia-Pacific Tuberculosis Vaccination Historic Market Size by Region
7.1.1 Asia-Pacific Tuberculosis Vaccination Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tuberculosis Vaccination Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Tuberculosis Vaccination Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Tuberculosis Vaccination Forecasted Market Size by Region
7.2.1 Asia-Pacific Tuberculosis Vaccination Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tuberculosis Vaccination Sales in Value by Region (2024-2029)
8 Latin America Tuberculosis Vaccination by Country
8.1 Latin America Tuberculosis Vaccination Historic Market Size by Country
8.1.1 Latin America Tuberculosis Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tuberculosis Vaccination Sales in Volume by Country (2018-2024)
8.1.3 Latin America Tuberculosis Vaccination Sales in Value by Country (2018-2024)
8.2 Latin America Tuberculosis Vaccination Forecasted Market Size by Country
8.2.1 Latin America Tuberculosis Vaccination Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tuberculosis Vaccination Sales in Value by Country (2024-2029)
9 Middle East and Africa Tuberculosis Vaccination by Country
9.1 Middle East and Africa Tuberculosis Vaccination Historic Market Size by Country
9.1.1 Middle East and Africa Tuberculosis Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tuberculosis Vaccination Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Tuberculosis Vaccination Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Tuberculosis Vaccination Forecasted Market Size by Country
9.2.1 Middle East and Africa Tuberculosis Vaccination Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tuberculosis Vaccination Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Tuberculosis Vaccination Products Offered
10.1.5 Merck Recent Development
10.2 Japan BCG Lab
10.2.1 Japan BCG Lab Company Information
10.2.2 Japan BCG Lab Introduction and Business Overview
10.2.3 Japan BCG Lab Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Japan BCG Lab Tuberculosis Vaccination Products Offered
10.2.5 Japan BCG Lab Recent Development
10.3 Serum Institute of India
10.3.1 Serum Institute of India Company Information
10.3.2 Serum Institute of India Introduction and Business Overview
10.3.3 Serum Institute of India Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Serum Institute of India Tuberculosis Vaccination Products Offered
10.3.5 Serum Institute of India Recent Development
10.4 AJ Vaccines
10.4.1 AJ Vaccines Company Information
10.4.2 AJ Vaccines Introduction and Business Overview
10.4.3 AJ Vaccines Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.4.4 AJ Vaccines Tuberculosis Vaccination Products Offered
10.4.5 AJ Vaccines Recent Development
10.5 BioFarma
10.5.1 BioFarma Company Information
10.5.2 BioFarma Introduction and Business Overview
10.5.3 BioFarma Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.5.4 BioFarma Tuberculosis Vaccination Products Offered
10.5.5 BioFarma Recent Development
10.6 GreenSignal Bio Pharma
10.6.1 GreenSignal Bio Pharma Company Information
10.6.2 GreenSignal Bio Pharma Introduction and Business Overview
10.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.6.4 GreenSignal Bio Pharma Tuberculosis Vaccination Products Offered
10.6.5 GreenSignal Bio Pharma Recent Development
10.7 China National Biotec
10.7.1 China National Biotec Company Information
10.7.2 China National Biotec Introduction and Business Overview
10.7.3 China National Biotec Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.7.4 China National Biotec Tuberculosis Vaccination Products Offered
10.7.5 China National Biotec Recent Development
10.8 Biomed Lublin
10.8.1 Biomed Lublin Company Information
10.8.2 Biomed Lublin Introduction and Business Overview
10.8.3 Biomed Lublin Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Biomed Lublin Tuberculosis Vaccination Products Offered
10.8.5 Biomed Lublin Recent Development
10.9 Taj Pharmaceuticals
10.9.1 Taj Pharmaceuticals Company Information
10.9.2 Taj Pharmaceuticals Introduction and Business Overview
10.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Taj Pharmaceuticals Tuberculosis Vaccination Products Offered
10.9.5 Taj Pharmaceuticals Recent Development
10.10 Ataulpho de Paiva
10.10.1 Ataulpho de Paiva Company Information
10.10.2 Ataulpho de Paiva Introduction and Business Overview
10.10.3 Ataulpho de Paiva Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Ataulpho de Paiva Tuberculosis Vaccination Products Offered
10.10.5 Ataulpho de Paiva Recent Development
10.11 IVAC – Institute of Vaccines and Medical Biologicals
10.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
10.11.2 IVAC – Institute of Vaccines and Medical Biologicals Introduction and Business Overview
10.11.3 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.11.4 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Products Offered
10.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Development
10.12 Queen Saovabha Mem. Inst
10.12.1 Queen Saovabha Mem. Inst Company Information
10.12.2 Queen Saovabha Mem. Inst Introduction and Business Overview
10.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccination Products Offered
10.12.5 Queen Saovabha Mem. Inst Recent Development
10.13 Microgen
10.13.1 Microgen Company Information
10.13.2 Microgen Introduction and Business Overview
10.13.3 Microgen Tuberculosis Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Microgen Tuberculosis Vaccination Products Offered
10.13.5 Microgen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tuberculosis Vaccination Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tuberculosis Vaccination Industrial Chain Analysis
11.4 Tuberculosis Vaccination Market Dynamics
11.4.1 Tuberculosis Vaccination Industry Trends
11.4.2 Tuberculosis Vaccination Market Drivers
11.4.3 Tuberculosis Vaccination Market Challenges
11.4.4 Tuberculosis Vaccination Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tuberculosis Vaccination Distributors
12.3 Tuberculosis Vaccination Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Immune Vaccine
Table 2. Major Company of Therapy Vaccine
Table 3. Global Tuberculosis Vaccination Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Tuberculosis Vaccination Sales by Type (2018-2024) & (K Units)
Table 5. Global Tuberculosis Vaccination Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Tuberculosis Vaccination Sales by Type (2018-2024) & (US& Million)
Table 7. Global Tuberculosis Vaccination Market Share in Value by Type (2018-2024)
Table 8. Global Tuberculosis Vaccination Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Tuberculosis Vaccination Sales by Type (2024-2029) & (K Units)
Table 10. Global Tuberculosis Vaccination Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Tuberculosis Vaccination Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Tuberculosis Vaccination Sales Market Share in Value by Type (2024-2029)
Table 13. Global Tuberculosis Vaccination Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Tuberculosis Vaccination Sales by Type (2018-2024) & (K Units)
Table 15. North America Tuberculosis Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Tuberculosis Vaccination Sales (K Units) by Type (2018-2024)
Table 17. Europe Tuberculosis Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Tuberculosis Vaccination Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Tuberculosis Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Tuberculosis Vaccination Sales (K Units) by Type (2018-2024)
Table 21. Latin America Tuberculosis Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Tuberculosis Vaccination Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Tuberculosis Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Tuberculosis Vaccination Sales by Company (2018-2024) & (K Units)
Table 25. Global Tuberculosis Vaccination Sales Share by Company (2018-2024)
Table 26. Global Tuberculosis Vaccination Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Tuberculosis Vaccination Revenue Share by Company (2018-2024)
Table 28. Global Market Tuberculosis Vaccination Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Tuberculosis Vaccination Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Tuberculosis Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccination as of 2022)
Table 32. Date of Key Manufacturers Enter into Tuberculosis Vaccination Market
Table 33. Key Manufacturers Tuberculosis Vaccination Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Tuberculosis Vaccination Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Tuberculosis Vaccination Sales by Region (2018-2024) & (K Units)
Table 37. Global Tuberculosis Vaccination Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Tuberculosis Vaccination Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Tuberculosis Vaccination Sales Market Share in Value by Region (2018-2024)
Table 40. Global Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Tuberculosis Vaccination Sales by Region (2024-2029) & (K Units)
Table 42. Global Tuberculosis Vaccination Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Tuberculosis Vaccination Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Tuberculosis Vaccination Sales Market Share in Value by Region (2024-2029)
Table 45. Global Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Tuberculosis Vaccination Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Tuberculosis Vaccination Sales by Application (2018-2024) & (K Units)
Table 48. Global Tuberculosis Vaccination Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Tuberculosis Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Tuberculosis Vaccination Sales Market Share in Value by Application (2018-2024)
Table 51. Global Tuberculosis Vaccination Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Tuberculosis Vaccination Sales by Application (2024-2029) & (K Units)
Table 53. Global Tuberculosis Vaccination Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Tuberculosis Vaccination Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Tuberculosis Vaccination Sales Market Share in Value by Application (2024-2029)
Table 56. Global Tuberculosis Vaccination Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Tuberculosis Vaccination Sales by Application (2018-2024) (K Units)
Table 58. North America Tuberculosis Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Tuberculosis Vaccination Sales by Application (2018-2024) (K Units)
Table 60. Europe Tuberculosis Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Tuberculosis Vaccination Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Tuberculosis Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Tuberculosis Vaccination Sales by Application (2018-2024) (K Units)
Table 64. Latin America Tuberculosis Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Tuberculosis Vaccination Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Tuberculosis Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Tuberculosis Vaccination Sales by Country (2018-2024) & (K Units)
Table 68. North America Tuberculosis Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Tuberculosis Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Tuberculosis Vaccination Sales Market Share in Value by Country (2018-2024)
Table 71. North America Tuberculosis Vaccination Sales by Country (2024-2029) & (K Units)
Table 72. North America Tuberculosis Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Tuberculosis Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Tuberculosis Vaccination Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Tuberculosis Vaccination Sales by Country (2018-2024) & (K Units)
Table 76. Europe Tuberculosis Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Tuberculosis Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Tuberculosis Vaccination Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Tuberculosis Vaccination Sales by Country (2024-2029) & (K Units)
Table 80. Europe Tuberculosis Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Tuberculosis Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Tuberculosis Vaccination Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Tuberculosis Vaccination Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Tuberculosis Vaccination Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Tuberculosis Vaccination Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Tuberculosis Vaccination Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Tuberculosis Vaccination Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Tuberculosis Vaccination Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Tuberculosis Vaccination Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Tuberculosis Vaccination Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Tuberculosis Vaccination Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Tuberculosis Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Tuberculosis Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Tuberculosis Vaccination Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Tuberculosis Vaccination Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Tuberculosis Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Tuberculosis Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Tuberculosis Vaccination Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Tuberculosis Vaccination Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Tuberculosis Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Tuberculosis Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Tuberculosis Vaccination Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Tuberculosis Vaccination Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Tuberculosis Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Tuberculosis Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Tuberculosis Vaccination Sales Market Share in Value by Country (2024-2029)
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Merck Tuberculosis Vaccination Product
Table 111. Merck Recent Development
Table 112. Japan BCG Lab Company Information
Table 113. Japan BCG Lab Introduction and Business Overview
Table 114. Japan BCG Lab Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Japan BCG Lab Tuberculosis Vaccination Product
Table 116. Japan BCG Lab Recent Development
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Introduction and Business Overview
Table 119. Serum Institute of India Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Serum Institute of India Tuberculosis Vaccination Product
Table 121. Serum Institute of India Recent Development
Table 122. AJ Vaccines Company Information
Table 123. AJ Vaccines Introduction and Business Overview
Table 124. AJ Vaccines Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. AJ Vaccines Tuberculosis Vaccination Product
Table 126. AJ Vaccines Recent Development
Table 127. BioFarma Company Information
Table 128. BioFarma Introduction and Business Overview
Table 129. BioFarma Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. BioFarma Tuberculosis Vaccination Product
Table 131. BioFarma Recent Development
Table 132. GreenSignal Bio Pharma Company Information
Table 133. GreenSignal Bio Pharma Introduction and Business Overview
Table 134. GreenSignal Bio Pharma Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. GreenSignal Bio Pharma Tuberculosis Vaccination Product
Table 136. GreenSignal Bio Pharma Recent Development
Table 137. China National Biotec Company Information
Table 138. China National Biotec Introduction and Business Overview
Table 139. China National Biotec Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. China National Biotec Tuberculosis Vaccination Product
Table 141. China National Biotec Recent Development
Table 142. Biomed Lublin Company Information
Table 143. Biomed Lublin Introduction and Business Overview
Table 144. Biomed Lublin Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Biomed Lublin Tuberculosis Vaccination Product
Table 146. Biomed Lublin Recent Development
Table 147. Taj Pharmaceuticals Company Information
Table 148. Taj Pharmaceuticals Introduction and Business Overview
Table 149. Taj Pharmaceuticals Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Taj Pharmaceuticals Tuberculosis Vaccination Product
Table 151. Taj Pharmaceuticals Recent Development
Table 152. Ataulpho de Paiva Company Information
Table 153. Ataulpho de Paiva Introduction and Business Overview
Table 154. Ataulpho de Paiva Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Ataulpho de Paiva Tuberculosis Vaccination Product
Table 156. Ataulpho de Paiva Recent Development
Table 157. IVAC – Institute of Vaccines and Medical Biologicals Company Information
Table 158. IVAC – Institute of Vaccines and Medical Biologicals Introduction and Business Overview
Table 159. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product
Table 161. IVAC – Institute of Vaccines and Medical Biologicals Recent Development
Table 162. Queen Saovabha Mem. Inst Company Information
Table 163. Queen Saovabha Mem. Inst Introduction and Business Overview
Table 164. Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Queen Saovabha Mem. Inst Tuberculosis Vaccination Product
Table 166. Queen Saovabha Mem. Inst Recent Development
Table 167. Microgen Company Information
Table 168. Microgen Introduction and Business Overview
Table 169. Microgen Tuberculosis Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Microgen Tuberculosis Vaccination Product
Table 171. Microgen Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Tuberculosis Vaccination Market Trends
Table 175. Tuberculosis Vaccination Market Drivers
Table 176. Tuberculosis Vaccination Market Challenges
Table 177. Tuberculosis Vaccination Market Restraints
Table 178. Tuberculosis Vaccination Distributors List
Table 179. Tuberculosis Vaccination Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccination Product Picture
Figure 2. Global Tuberculosis Vaccination Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Tuberculosis Vaccination Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Tuberculosis Vaccination Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Immune Vaccine
Figure 6. Global Immune Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Therapy Vaccine
Figure 8. Global Therapy Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Tuberculosis Vaccination Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Tuberculosis Vaccination Sales Market Share by Type in 2022 & 2029
Figure 11. North America Tuberculosis Vaccination Sales Market Share in Volume by Type in 2022
Figure 12. North America Tuberculosis Vaccination Sales Market Share in Value by Type in 2022
Figure 13. Europe Tuberculosis Vaccination Sales Market Share in Volume by Type in 2022
Figure 14. Europe Tuberculosis Vaccination Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Tuberculosis Vaccination Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Tuberculosis Vaccination Sales Market Share in Value by Type in 2022
Figure 17. Latin America Tuberculosis Vaccination Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Tuberculosis Vaccination Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Tuberculosis Vaccination Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Tuberculosis Vaccination Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Vaccination Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Vaccination Revenue in 2022
Figure 23. Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Self-Procurement
Figure 25. Global Self-Procurement Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of UNICEF
Figure 27. Global UNICEF Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Tuberculosis Vaccination Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Tuberculosis Vaccination Sales Market Share by Application in 2022 & 2029
Figure 32. North America Tuberculosis Vaccination Sales Market Share in Volume by Application in 2022
Figure 33. North America Tuberculosis Vaccination Sales Market Share in Value by Application in 2022
Figure 34. Europe Tuberculosis Vaccination Sales Market Share in Volume by Application in 2022
Figure 35. Europe Tuberculosis Vaccination Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Tuberculosis Vaccination Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Tuberculosis Vaccination Sales Market Share in Value by Application in 2022
Figure 38. Latin America Tuberculosis Vaccination Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Tuberculosis Vaccination Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Tuberculosis Vaccination Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Tuberculosis Vaccination Manufacturing Cost Structure
Figure 43. Tuberculosis Vaccination Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed